Bina Therapeutics Publishes Preclinical Results of TRAABA24
TRAABA24 Preclinical Results Share This Article: Abstract Background: Pseudomyxoma peritonei (PMP) is a rare malignancy with limited treatment options. Mitomycin C (MMC) is a frontline chemotherapeutic used in hyperthermic intraperitoneal chemotherapy (HIPEC) due to its potent cytotoxicity via DNA cross-linking. However, its severe systemic toxicity restricts use to localized administration. TRAABA24, a lipid nanoparticle (LNP) […]
Early Calibration of TRAABA24 Shows Promising Initial Results in PMP
Preclinical Study Progress Update Share This Article: Early Calibration of TRAABA24 Lipid Nanoparticle Show Promising Initial Results in PMP. Over the last few weeks we initiated the calibration of lab conditions to ensure consistency and accuracy in our preclinical studies. As part of this process, we conducted initial testing of TRAABA24 encapsulated in a lipid […]
Successful Culturing of Primary Cells for PMP Research
Milestone Update Share This Article: Successful Culturing of Primary Cells for PMP Research In December 2024, thanks to collaboration with researchers at the University of South Carolina, Bina Therapeutics achieved a significant milestone by establishing a master cell bank for our Pseudomyxoma Peritonei (PMP) research. As we begin 2025, we are pleased to share the […]
Bina Therapeutics establishes a master cell bank for PMP research
Milestone Update Share This Article: Establishment PMP Cell Culture Collection As part of our commitment to keeping you informed, we’re thrilled to announce that Bina Therapeutics has established its master cell bank for development! Thanks to the generosity and relentless support of our collaborative partners, the preclinical validation of TRAABA24 can now begin. Pseudomyxoma Peritonei (PMP) is […]
From Frustration to Innovation: Fighting Rare Diseases with Bina Therapeutics
From Frustration to Innovation Share This Article: “Wake up, something is wrong with me…” These are the words I frequently woke up to when my wife came home from her 3 week hospital stay. She was treated for a rare cancer called Pseudomyxoma Peritonei (PMP), spending almost a year learning how to live without the […]
Protected: Computational Drug Discovery for Pseudomyxoma Peritonei
There is no excerpt because this is a protected post.
